Ovarian and gynaecological cancer treatment
The combination of surgery, chemotherapy, targeted drugs and sometimes radiotherapy used to treat cancers of the ovaries, fallopian tubes, womb, cervix or vulva, planned by a specialist team based on the type and stage of the cancer.
✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review
In short
- Gynaecological cancer treatment is usually a combination of surgery, chemotherapy, targeted drugs and sometimes radiotherapy, chosen by a specialist team based on the exact type and stage.
- No one can guarantee a cure. Your team will tell you honestly whether treatment is aiming to cure the cancer or to control it and ease symptoms.
- Outlook depends heavily on the stage when the cancer is found, the cell type and your general health — survival figures are averages and cannot predict any one person's outcome.
- Almost all of this care is delivered and funded by the NHS through a cancer team; private input is usually about speed, choice or a second opinion, not a better cure.
A plain-English summary. The detail — including risks and recovery — is below.
At a glance
A general guide. Your specialist will give you advice for your situation.
Surgery can remove cancer and, when all visible disease is removed, gives the best chance of a good outcome for some cancers.
Intensive surgery or chemotherapy may not be advisable if you are too frail or have other serious illnesses that make the risks outweigh the benefits.
You will have regular reviews. Side effects are managed as they arise, and doses can be adjusted. Tell your team about new symptoms early rather than...
A named clinical nurse specialist or key worker as your point of contact
You will have regular reviews. Side effects are managed as they arise, and doses can be adjusted. Tell your team...
Wound healing, gradually increasing activity, and avoiding heavy lifting. Major abdominal surgery can take several...
Many side effects ease over the following weeks, though tiredness and changes such as menopausal symptoms or...
Some people then take a targeted drug (such as a PARP inhibitor) for many months, with ongoing monitoring of blood...
What is ovarian and gynaecological cancer treatment?
Gynaecological cancers are cancers that start in a woman's reproductive system — the ovaries, fallopian tubes, the lining of the abdomen (peritoneum), the womb (endometrium), the cervix or the vulva. Treatment usually means a combination of approaches rather than one single thing: surgery, chemotherapy, targeted drugs (such as PARP inhibitors or bevacizumab), and sometimes radiotherapy or hormone treatment.
The right combination depends heavily on which organ the cancer started in, the exact cell type, the grade, and the stage (how far it has spread). For this reason, every plan is made by a multidisciplinary team (MDT) — surgeons, medical oncologists, clinical oncologists, pathologists, radiologists and specialist nurses — after the cancer has been examined under a microscope and staged with scans.
The aim of treatment is described honestly as either curative intent (trying to remove or destroy the cancer and reduce the chance of it coming back) or palliative intent (trying to control the cancer, ease symptoms and protect quality of life when cure is not realistic). The same drugs can be used with either aim, so it is important to ask your team which applies to you.
This guide is an overview of the whole pathway. It cannot promise a cure, it cannot give you a number for your own outlook, and it is not a substitute for the detailed conversation you should have with your own gynaecological oncology team.
Types, options & approaches
There may be different ways to do this. The right approach depends on the clinical question and your circumstances.
Curative-intent versus palliative-intent treatment
| Question | Curative intent | Palliative intent |
|---|---|---|
| Main aim | Remove or destroy the cancer; lower the chance of return | Control the cancer; ease symptoms; protect quality of life |
| Typical stage | Earlier or fully removable disease | Advanced or widespread disease |
| Treatment intensity | May be more intensive (e.g. big surgery plus chemo) | Balanced against side effects and wellbeing |
| What to ask | What is my chance of it coming back? | How will this help me feel, and for how long? |
The same drug can be used with either aim. Always ask your team which intent applies to you — it should be stated clearly and kindly.
Preparing for your treatment
- Make sure your diagnosis has been confirmed under a microscope (histology) and that your cancer has been staged with scans before a treatment plan is finalised.
- Ask whether your case has been discussed by the gynaecological cancer multidisciplinary team (MDT), and what they recommended.
- Bring a list of all your medicines and supplements, as some interact with chemotherapy or targeted drugs.
- Ask about fertility before treatment starts if this matters to you — some treatments affect fertility permanently and options may need arranging first.
- Ask whether genetic testing (for example BRCA) is relevant, as it can affect both your treatment and advice for your family.
- Plan practical support: time off work, help at home, and transport to chemotherapy or radiotherapy appointments.
- Write down your questions, and consider bringing someone with you to appointments to help remember information.
What happens
After tests confirm the type and stage, your case is discussed by the MDT, who recommend a plan. You then meet the relevant specialists — a gynaecological oncology surgeon, a medical oncologist (for chemotherapy and targeted drugs) and/or a clinical oncologist (for radiotherapy) — to talk through the options, the aim of treatment and the likely side effects.
If surgery is part of the plan, it is done under general anaesthetic and may involve removing the ovaries, womb, fallopian tubes and other affected tissue, with a stay in hospital afterwards. The removed tissue is examined to confirm the stage.
Chemotherapy is usually given in the day unit through a drip, in cycles spread over months, with blood tests and check-ups between cycles. Targeted drugs may be tablets you take at home. Radiotherapy, where used, is given as a course of short daily sessions over several weeks.
Throughout, a clinical nurse specialist is usually your main point of contact, and your response is reviewed with scans, examinations and sometimes the CA125 blood test for ovarian cancer.
Is this treatment right for me?
A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.
May not be suitable if…
- Intensive surgery or chemotherapy may not be advisable if you are too frail or have other serious illnesses that make the risks outweigh the benefits.
- Some targeted drugs only help particular cancer types or gene profiles and will not work for everyone.
- Treatment with curative intent may not be possible if the cancer is very advanced; the focus then shifts to control and comfort.
- A treatment that has already stopped working is usually not simply repeated; the plan is changed instead.
Delay or rearrange if…
- There is an active, untreated infection that needs sorting first.
- Essential staging scans or pathology results are still missing, so the right plan cannot yet be chosen.
- Fertility preservation is wanted and has not yet been arranged where this is possible.
- Your blood counts are too low to give the next cycle of chemotherapy safely.
- You have not yet had a proper discussion of the aim, risks and alternatives.
Alternatives to discuss
- Supportive (palliative) care alone, focusing on symptoms and quality of life, if active treatment is not wanted or not advisable
- A different drug, a gentler regimen, or hormone therapy for suitable womb or ovarian cancers
- Active monitoring in selected very early or low-grade cancers, where appropriate
- A clinical trial, if one is open and suitable for your cancer
- A second opinion from another gynaecological cancer centre
Before you decide
Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.
What matters most to me?
Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.
What are all my options?
Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.
What would make me pause?
Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.
What happens if I do nothing today?
For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.
Comfort, sedation or contrast choices
If local anaesthetic, sedation, contrast or pain relief is used, ask what is planned, why, and what it means afterwards.
Benefits
- Surgery can remove cancer and, when all visible disease is removed, gives the best chance of a good outcome for some cancers.
- Chemotherapy can shrink cancer, treat disease that cannot be seen, and is sometimes given before surgery to make an operation possible.
- Targeted maintenance drugs such as PARP inhibitors can, for selected people, delay the cancer coming back.
- Radiotherapy and chemoradiotherapy can be very effective main treatments for some cervical and vulval cancers.
- Treatment can relieve symptoms such as pain, bleeding or a swollen abdomen, even when cure is not possible.
- A team-based plan means decisions are shared across specialists rather than left to one person.
Risks & complications
- Tiredness, which can build up over a course of treatment
- Chemotherapy side effects such as nausea, hair loss, mouth soreness and a drop in blood counts
- Surgical recovery: pain, wound healing, and a longer recovery after major abdominal surgery
- Early menopause and loss of fertility if the ovaries or womb are removed or affected by treatment
- Emotional impact, including anxiety, low mood and uncertainty
- Infection during chemotherapy when blood counts are low (this can become serious quickly)
- Blood clots in the legs or lungs
- Nerve damage from some chemotherapy drugs (tingling or numbness in hands and feet)
- Bowel or bladder problems after surgery or radiotherapy
- Targeted-drug side effects such as high blood pressure or, rarely, bowel problems with bevacizumab
- Life-threatening infection (sepsis) during low-blood-count periods
- Serious bleeding or damage to nearby organs during surgery
- Severe reactions to chemotherapy or targeted drugs
- Second cancers many years after some treatments, including certain chemotherapy or radiotherapy
The biggest uncertainties are whether treatment will control the cancer and for how long, and how well you will tolerate it. Both depend on the type and stage of cancer and on your general health. Ask your team clearly: is this treatment trying to cure the cancer or to control it, what side effects are most likely for me, and what is the plan if treatment does not work as hoped.
Published figures to discuss
Survival and response vary enormously by cancer type, cell type, grade and especially stage, and the figures below are population averages from Cancer Research UK, not predictions for any individual. They describe net survival (survival from the cancer itself). They cannot tell you what will happen to you, and they do not capture quality of life or newer treatments. Use them only to understand that stage matters, and discuss your own situation with your team.
| Figure | Reported range | How to interpret it | Source / confidence |
|---|---|---|---|
| Ovarian cancer surviving 5 years or more — stage 1 | Around 95 in 100 (about 95%) | Cancer Research UK, England 2016–2020. Early-stage disease has a much better outlook; most ovarian cancer is sadly found later. | Cancer Research UK — Treatment for ovarian cancercancerresearchuk.orgPublished figure |
| Ovarian cancer surviving 5 years or more — stage 3 | More than 30 in 100 (more than 30%) | Cancer Research UK, England 2016–2020. Shows how strongly outlook falls with stage; an average, not a prediction. | Cancer Research UK — Treatment for ovarian cancercancerresearchuk.orgPublished figure |
| Ovarian cancer surviving 5 years or more — stage 4 | Around 15 in 100 (about 15%) | Cancer Research UK, England 2016–2020. People can live well beyond the average; figures cannot predict individuals. | Cancer Research UK — Treatment for ovarian cancercancerresearchuk.orgPublished figure |
These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.
What happens afterwards
Recovery from gynaecological cancer treatment is not a single event but a gradual process over months. After surgery there is a physical recovery; after chemotherapy and radiotherapy, energy and wellbeing usually return slowly once treatment ends, though some effects can be longer-lasting.
- Feeling more tired than usual for weeks or months after treatment
- Menopausal symptoms (hot flushes, dryness) if the ovaries are removed or affected
- Changes in bowel or bladder habit after pelvic surgery or radiotherapy
- Ups and downs in mood while waiting for scan results
- Gradually rebuilding strength and stamina rather than bouncing straight back
Aftercare
- Keep a written record of your treatment, drug names and doses, and your team's contact numbers.
- Follow advice on what to do if you develop a fever or feel unwell during chemotherapy — this can be an emergency.
- Take targeted-drug tablets exactly as prescribed and attend the blood-test monitoring that goes with them.
- Ask about menopause symptom support if your ovaries are removed or stop working.
- Use prescribed anti-sickness medicines and report poorly controlled nausea so it can be adjusted.
- Attend all follow-up scans and appointments, and report new or returning symptoms promptly.
- Accept practical and emotional support — clinical nurse specialists and charities can help with both.
- A written treatment plan stating the aim (curative or palliative)
- The name and number of your clinical nurse specialist or key worker
- Clear written instructions on when to phone urgently (e.g. fever during chemo)
- Anti-sickness and other supportive medicines collected
- Transport and time off work arranged for treatment days
- Questions about fertility and genetics raised before treatment starts
- Someone to support you at appointments and at home
⚠ Get urgent help if…
- A temperature, shivering or feeling very unwell during chemotherapy — this can mean a serious infection and needs urgent assessment, often the same hour
- Heavy or unexpected vaginal bleeding
- Severe abdominal pain, a swollen tummy or being unable to keep fluids down
- A swollen, painful calf, or sudden breathlessness or chest pain (possible blood clot)
- Severe diarrhoea or signs of dehydration during treatment
- Yellowing of the skin or eyes, or confusion
- Any symptom your team has told you to report urgently
Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.
General guidance — it doesn't replace the specific advice your specialist gives you.
Results & realistic expectations
A good response means the cancer shrinks, disappears on scans, or is controlled, and that symptoms improve while side effects stay manageable. For ovarian cancer the CA125 blood test, alongside scans and examination, helps track response. A normal scan or falling blood marker is encouraging but does not prove the cancer is gone for good, which is why follow-up continues.
It is important to understand that response varies a great deal between people and cancer types, and that even successful treatment carries a chance of the cancer returning. Your team can explain what your results mean for you, but cannot give a guarantee.
How long the benefit of treatment lasts depends on the cancer type, the stage, how completely it was removed or controlled, and the biology of the individual cancer. Some gynaecological cancers are cured, especially when found early; others tend to come back and are then managed as a long-term condition with further lines of treatment. Maintenance drugs aim to extend the time before return for selected people. Your team will explain the realistic picture for your situation.
Related tests, treatments or support
Gynaecological cancer treatment usually combines several approaches in a planned sequence — for example surgery and chemotherapy, or chemotherapy and radiotherapy together (chemoradiotherapy) for some cervical cancers. Supportive care, fertility advice, genetic testing and menopause care are often arranged alongside the main cancer treatment.
Follow-up & long-term care
After treatment you are followed up with appointments, examinations and scans, and sometimes blood tests such as CA125. The schedule depends on the cancer type and your risk of recurrence. The purpose is to check how you are, manage side effects and pick up any sign of the cancer returning. You should also be told who to contact, and how quickly, if you notice new symptoms between appointments.
- Ongoing tablets such as PARP inhibitors for selected people, with regular blood-count monitoring
- Long-term menopause symptom support if the ovaries are removed or stop working
- Pelvic-floor or bowel/bladder rehabilitation after pelvic surgery or radiotherapy
- Regular follow-up scans or blood tests on a schedule set by your team
- Bone-health and general-health checks, as some treatments affect these over time
Repeat, follow-on and what comes next
- Treatment is often given in lines: if one stops working, the team moves to a different drug or approach rather than repeating the same one.
- Ovarian cancer in particular may respond, settle, then return, and is then treated again — sometimes over several years.
- Doses are commonly adjusted or paused to manage side effects, which is normal and not a failure.
- Surgery is sometimes staged, and occasionally a second operation is considered if the situation changes.
Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.
What good aftercare looks like
- A named clinical nurse specialist or key worker as your point of contact
- Clear, written emergency instructions, especially about fever and infection during chemotherapy
- Organised follow-up with scans, examination and blood tests as appropriate
- Access to menopause care, fertility advice, psychological support and palliative care when needed
- Coordination with your NHS team and GP so nothing falls through the gaps
What affects the cost
Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:
- Whether the plan involves surgery, chemotherapy, targeted drugs, radiotherapy or a combination
- The number of chemotherapy cycles and the specific drugs used
- Hospital or facility fees and any inpatient stay for surgery
- Scans and pathology, including specialist tumour and genetic testing
- Specialist nurse support, supportive medicines and anti-sickness treatment
- Follow-up scans and appointments over months or years
- Whether care is coordinated with the NHS, which funds most cancer treatment
- Exactly which treatments are included, and the aim (curative or palliative)
- Consultant (surgeon and oncologist) fees and facility/theatre fees
- Drug costs, including newer targeted drugs, and how many cycles are planned
- Scans, pathology and any genetic testing
- Supportive care, anti-sickness medicines and clinical nurse specialist access
- Follow-up appointments and scans after treatment
- What happens, and who pays, if a complication occurs or treatment needs changing
On the NHS? Almost all gynaecological cancer treatment is provided and funded by the NHS through a specialist multidisciplinary team; private care is generally used for speed, choice or a second opinion rather than for a different chance of cure.
You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.
Consent traps and marketing red flags
These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.
Consent traps
- Not being told clearly whether the aim is to cure the cancer or to control it.
- No honest discussion of side effects, fertility loss or early menopause before treatment starts.
- Genetic testing (such as BRCA) not being offered when it could change treatment or matter to family.
- Being offered an expensive private treatment as if it improves the chance of cure when the NHS would offer the same.
- No clear written plan for what to do if you become unwell during chemotherapy.
Marketing red flags
- Any clinic promising a cure, a guaranteed response or a treatment that 'the NHS won't give you' for cancer
- Unproven 'miracle cure', detox, high-dose vitamin or alternative therapies promoted instead of standard treatment
- Pressure to pay quickly for treatment without MDT review or proper staging
- Downplaying serious side effects or the possibility that treatment may not work
- Discouraging you from continuing NHS care or seeking a second opinion
Choosing a specialist safely
- Check the specialist is on the GMC Specialist Register for this area.
- Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
- You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
- Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
- You're entitled to your total cost in writing — including any follow-up — before you decide.
Questions to ask your medical professional
Take this to your consultation. A good specialist will welcome every one of these.
- What type and stage of gynaecological cancer do I have, and was my case discussed by the MDT?
- Is the aim of my treatment to cure the cancer or to control it and ease symptoms?
- What combination of surgery, chemotherapy, targeted drugs or radiotherapy do you recommend, and why?
- How will this affect my fertility and my menopause, and can anything be done about that?
- Is genetic testing such as BRCA relevant for me and my family?
- What are the most likely side effects for me, and what is the plan if the treatment does not work as hoped?
- Who is my main point of contact, and when should I ring urgently?
- Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
- Will you be the specialist who carries out my treatment, and who looks after me afterwards?
- What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
- What does a realistic result look like — and what can this treatment not achieve?
- What are my options, including waiting, doing nothing for now, or choosing a different approach?
- Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
- What is the total cost in writing, including any follow-ups, and how much time do I have to decide?
Frequently asked questions
Can paying privately get me a better chance of a cure?
Will treatment cure my cancer?
Will I lose my fertility?
What is a PARP inhibitor?
Why do I need to know about BRCA genes?
Why does everyone keep talking about staging?
Find a verified specialist for ovarian and gynaecological cancer treatment
Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.
No verified consultants list this procedure yet — browse the full directory.
How we made this page
Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →
Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.
Sources & standards: NICE — Ovarian cancer: recognition and initial management (CG122) Cancer Research UK — Treatment for ovarian cancer Cancer Research UK — Ovarian cancer survival by stage Target Ovarian Cancer — Targeted treatments Macmillan — Womb (uterine) cancer NHS — Ovarian cancer
Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.
Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.
Related guides: Melanoma diagnosis and treatment · Cancer of unknown primary assessment · Kidney removal (nephrectomy) · Bladder and kidney cancer treatment · Bowel (colorectal) cancer treatment